{
  "guideline": {
    "id": "PA166328661",
    "name": "FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]: Abacavir - HLA-B",
    "objCls": "PGx Association",
    "source": "FDA",
    "version": 0,
    "url": "https://www.pharmgkb.org/fdaPgxAssociations#PA166328661",
    "relatedChemicals": [
      {
        "id": "PA448004",
        "name": "abacavir",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA35056",
        "name": "major histocompatibility complex, class I, B",
        "symbol": "HLA-B"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166310781",
      "name": "Recommendation Annotation PA166310781",
      "population": "Affected subgroup: HLA-B*57:01 allele positive",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA448004",
          "name": "abacavir",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452213220,
        "html": "<p>&quot;Results in higher adverse reaction risk (hypersensitivity reactions). Do not use abacavir in patients positive for HLA-B*57:01.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "HLA-B": "*57:01 positive"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [],
  "version": "2024-03-08-14-34"
}